Explore more publications!
Asia Healthcare Industry Digest
Got News to Share?

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 23, 2026

AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass
Mar. 23, 2026

AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass

Indeterminate GlobeNewswire
Naples Comprehensive Health Announces Jeff Wyler to Board of Trustees
Mar. 23, 2026

Naples Comprehensive Health Announces Jeff Wyler to Board of Trustees

Indeterminate GlobeNewswire
Children’s National launches Division of AI Research to lead the future of artificial intelligence in pediatric medicine
Mar. 23, 2026

Children’s National launches Division of AI Research to lead the future of artificial intelligence in pediatric medicine

Indeterminate GlobeNewswire
Dermal Filler Market 2026 growing with demand for non-surgical aesthetic procedures
Mar. 23, 2026

Dermal Filler Market 2026 growing with demand for non-surgical aesthetic procedures

Indeterminate EIN Presswire
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors
Mar. 23, 2026

Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors

Indeterminate GlobeNewswire
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test
Mar. 23, 2026

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

Indeterminate GlobeNewswire
Vantive Accelerates U.S. Home Therapy Transformation With New Digital and Patient Support Innovations
Mar. 23, 2026

Vantive Accelerates U.S. Home Therapy Transformation With New Digital and Patient Support Innovations

Indeterminate GlobeNewswire
SafeSpace Global Secures Shareholder Approval to Increase Authorized Shares of Common Stock
Mar. 23, 2026

SafeSpace Global Secures Shareholder Approval to Increase Authorized Shares of Common Stock

Indeterminate GlobeNewswire
Cortexa Advances Commercialisation of MDMA Supply in Australia
Mar. 23, 2026

Cortexa Advances Commercialisation of MDMA Supply in Australia

Indeterminate GlobeNewswire
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
Mar. 23, 2026

China SXT Pharmaceuticals, Inc. Announces Share Re-classification

Indeterminate GlobeNewswire
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference
Mar. 23, 2026

Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference

Indeterminate GlobeNewswire
Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
Mar. 23, 2026

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

Indeterminate GlobeNewswire
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
Mar. 23, 2026

Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group

Indeterminate GlobeNewswire
Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET
Mar. 23, 2026

Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8:30 AM ET

Indeterminate GlobeNewswire
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
Mar. 23, 2026

NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update

Indeterminate GlobeNewswire
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split
Mar. 23, 2026

Onconetix, Inc. Announces 1-for-5 Reverse Stock Split

Indeterminate GlobeNewswire
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement
Mar. 23, 2026

RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement

Indeterminate GlobeNewswire
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
Mar. 23, 2026

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

Indeterminate GlobeNewswire
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
Mar. 23, 2026

TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

Indeterminate GlobeNewswire
Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Mar. 23, 2026

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions